psychedelic-banner

Psychedelic Research Studies

Segal Trials is the first to offer psychedelic research in Florida and is pioneering the way for advancements in medicine for the entire country.

We offer a full-service center dedicated to Psychedelic Research. With state-of-the-art equipment in a relaxed and comfortable setting to accommodate our participants. The doctors and staff are experts in the field of psychedelics. Segal Trials has a proven record of 23 years as private research experts changing the treatment paradigm for psychiatric, neurological, and women’s health disorders.

You can be a hero and make medical history by joining one of our psychedelic clinical research trials.

Note: Psychedelic Studies Are Conducted In South Florida.

Participate in our New Clinical Research Study for Generalized Anxiety Disorder Segal Trials is currently conducting a clinical research study to evaluate participants who experience symptoms of General Anxiety Disorder.

Study Details

  • Adults 18-74 years old
  • Diagnosed with Generalized Anxiety Disorder (GAD)
  • Must be in medically stable condition (no high blood pressure)
  • Participation in the trial will last approximately 17 week
  • No history of illicit use of substances 
  • No substance or alcohol use disorder within the past 12 months
  • Must agree to use highly effective birth control methods during the study 
  • No diagnosis or a first-degree relative diagnosed with Schizophrenia, Psychotic disorder, or Bipolar
  • Additional criteria may apply

Participants who qualify may receive: 

  • Study Related Exams and Lab Work at No
  • Cost Compensation for time and travel up to $900
  • Free transportation available

Anxiety Study

"*" indicates required fields

Name*

Study Details:

•Men and women 18 years or older

• Diagnosed with Major Depression & past medications have failed

• Currently taking an antidepressant

• Have not been diagnosed with the following: Bipolar, Schizophrenia, PTSD, OCD, Anorexia Nervosa

Depression Study – TRD

"*" indicates required fields

Name*

Study Details:

•Men and women 18 years or older

• Diagnosed or experience symptoms of Depression

• Be able to participate in a Video Call

• Good physical health

• Study length: up to 1 year

General Depression

"*" indicates required fields

Name*

Study Details:

• 18 years or older
• Diagnosis of moderate to severe alcohol use disorder and otherwise be healthy

Alcohol Use Disorder Study

"*" indicates required fields

Name*

Psychedelic Studies Clinical Team

Dr. Rishi Kakar

• Chief Scientific Officer • Medical Director and Principal Investigator • Board Certified Psychiatrist • Diplomate, American Board of Psychiatry and Neurology

Dr. Kristin Hicks

• Psychedelics Therapist

Sarah Coleman

• Screening Specialist / Psychedelics Facilitator

Dr. Scott Fisher

• Lead Psychedelics Therapist

Dr. Eva Nowakowski Sims

• Psychedelics Therapist